IMUNON Announces PlaCCine\u00ae DNA Vaccine Technology Abstract Selected for Oral Presentation at 10th International Conference

  • Clinical Data Highlight PlaCCine's Six-Month Durability, Temperature Stability, and Manufacturing Advantages Over mRNA Vaccines